1. Methods of Economic Evaluation for the German Statutory Healthcare System

   • Hengjin Dong

   Editorial 17 September 2012 Pages: 1 - 4

   

2. The Applicability and Generalizability of Findings from Clinical Trials for Health-Policy Decisions

   • Nick Freemantle
   • Franz Hessel

   Current Opinion 17 September 2012 Pages: 5 - 10

   

3. Is Medication Review by Primary-Care Pharmacists for Older People Cost Effective?

   • Arnold G. Zermansky
   • Jonathan Silcock

   Review Article 17 September 2012 Pages: 11 - 24

   

4. Statin Therapy in Rheumatoid Arthritis

   • Nick Bansback
   • Roberta Ara
   • Hyon K. Choi

   Original Research Article 17 September 2012 Pages: 25 - 37

   

5. Treating Relapsing Multiple Sclerosis with Subcutaneous versus Intramuscular Interferon-Beta-1a

   • Shien Guo
   • Duygu Bozkaya
   • Dennis M. Meletiche

   Original Research Article 17 September 2012 Pages: 39 - 53

   

6. Cost Effectiveness of High-Dose Chemotherapy with Autologous Stem Cell Support as Initial Treatment of Aggressive Non-Hodgkin’s Lymphoma

   • Philippe Fagnoni
   • Noel Milpied
   • Marie-Christine Woronoff-Lemsi

   Original Research Article 17 September 2012 Pages: 55 - 68

   

7. Comparing the Cost Effectiveness of Risperidone and Olanzapine in the Treatment of Schizophrenia Using the Net-Benefit Regression Approach

   • Annemieke De Ridder
   • Diana De Graeve

   Original Research Article 17 September 2012 Pages: 69 - 80

   

8. Estimating the Cost of Diabetes Mellitus-Related Events from Inpatient Admissions in Sweden Using Administrative Hospitalization Data

   • Ulf-G Gerdtham
   • Philip Clarke
   • Soffia Gudbjornsdottir

   Original Research Article 17 September 2012 Pages: 81 - 90